Drug trial aims to stop lupus before it starts
NCT ID NCT03030118
Summary
This study tested whether hydroxychloroquine, a common lupus medication, could prevent people with early signs of lupus from developing the full disease. Researchers gave the drug or a placebo to 187 people aged 15-49 who showed some lupus markers but didn't yet have the full condition. The goal was to see if early treatment could slow or stop disease progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Northwell Health
Great Neck, New York, 11021, United States
-
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma, 73104, United States
-
Penn State MS Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.